SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-24-138321
Filing Date
2024-05-14
Accepted
2024-05-14 16:43:56
Documents
13
Period of Report
2024-05-09
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year

Document Format Files

Seq Description Document Type Size
1 8-K d836013d8k.htm   iXBRL 8-K 23514
  Complete submission text file 0001193125-24-138321.txt   145083

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA ttoo-20240509.xsd EX-101.SCH 2866
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE ttoo-20240509_lab.xml EX-101.LAB 17981
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ttoo-20240509_pre.xml EX-101.PRE 11269
16 EXTRACTED XBRL INSTANCE DOCUMENT d836013d8k_htm.xml XML 3705
Mailing Address 101 HARTWELL AVENUE LEXINGTON MA 02421
Business Address 101 HARTWELL AVENUE LEXINGTON MA 02421 781-457-1200
T2 Biosystems, Inc. (Filer) CIK: 0001492674 (see all company filings)

IRS No.: 204827488 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36571 | Film No.: 24945211
SIC: 3841 Surgical & Medical Instruments & Apparatus
(CF Office: 08 Industrial Applications and Services)